Genelux Common Valuation
| GNLX Stock | 2.69 0.20 8.03% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. Genelux Common retains a regular Real Value of USD2.24 per share. The prevalent price of the firm is USD2.69. Our model calculates the value of Genelux Common from evaluating the firm fundamentals such as Return On Equity of -0.89, return on asset of -0.45, and Shares Owned By Insiders of 16.28 % as well as inspecting its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Genelux Common's valuation include:
Price Book 2.8076 | Enterprise Value 60.9 M | Enterprise Value Ebitda (327.19) | Price Sales 11.6 K | Enterprise Value Revenue 7.6 K |
Overvalued
Today
Please note that Genelux Common's price fluctuation is dangerous at this time. Calculation of the real value of Genelux Common is based on 3 months time horizon. Increasing Genelux Common's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Genelux Common is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Genelux Stock. However, Genelux Common's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.69 | Real 2.24 | Target 34.33 | Hype 2.69 | Naive 2.81 |
The intrinsic value of Genelux Common's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Genelux Common's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Genelux Common helps investors to forecast how Genelux stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Genelux Common more accurately as focusing exclusively on Genelux Common's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Genelux Common's intrinsic value based on its ongoing forecasts of Genelux Common's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Genelux Common's closest peers.
Genelux Common Cash |
|
Genelux Valuation Trend
Analysing the historical paterns of Genelux Common's enterprise value and its market capitalization is a good way to estimate and gauge the value of Genelux Common over time and is usually enough for investors to make rational market timing decisions.
Genelux Common Total Value Analysis
Genelux Common is currently expected to have valuation of 60.89 M with market capitalization of 92.91 M, debt of 2.52 M, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Genelux Common fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
60.89 M | 92.91 M | 2.52 M |
Genelux Common Investor Information
About 16.0% of the company shares are held by company insiders. The book value of Genelux Common was currently reported as 0.74. The company recorded a loss per share of 0.94. Genelux Common had not issued any dividends in recent years. Based on the analysis of Genelux Common's profitability, liquidity, and operating efficiency, Genelux Common is not in a good financial situation at this time. It has a very high odds of going through financial crisis in January.Genelux Common Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Genelux Common has an asset utilization ratio of 0.61 percent. This suggests that the Company is making USD0.006095 for each dollar of assets. An increasing asset utilization means that Genelux Common is more efficient with each dollar of assets it utilizes for everyday operations.Genelux Common Ownership Allocation
Genelux Common has a total of 34.54 Million outstanding shares. Genelux Common retains 16.28 (percent) of its outstanding shares held by insiders and 15.7 (percent) owned by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Genelux Common Profitability Analysis
The company reported the previous year's revenue of 170 K. Net Loss for the year was (28.3 M) with profit before overhead, payroll, taxes, and interest of 11.07 M.About Genelux Common Valuation
Our relative valuation model uses a comparative analysis of Genelux Common. We calculate exposure to Genelux Common's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Genelux Common's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -848 K | -805.6 K | |
| Pretax Profit Margin | (166.45) | (174.78) | |
| Operating Profit Margin | (142.15) | (149.25) | |
| Net Loss | (166.45) | (174.78) | |
| Gross Profit Margin | (4.99) | (4.74) |
Genelux Common Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 24.4 M |
Genelux Common Current Valuation Indicators
Valuation refers to the process of determining the present value of Genelux Common and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Genelux we look at many different elements of the entity such as Genelux's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Genelux Common, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Genelux Common's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Genelux Common's worth.Additional Tools for Genelux Stock Analysis
When running Genelux Common's price analysis, check to measure Genelux Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genelux Common is operating at the current time. Most of Genelux Common's value examination focuses on studying past and present price action to predict the probability of Genelux Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genelux Common's price. Additionally, you may evaluate how the addition of Genelux Common to your portfolios can decrease your overall portfolio volatility.